A Phase 2 clinical trial finds that ALT flares are common in hepatitis D patients treated with pegylated interferon-alpha, ...

The global interferons market is on a steady growth trajectory, with its valuation projected to surge from USD 9.4 billion in 2022 to USD 13.8 billion by 2032. According to a recent report by Future ...

Douglas A. Tremblay, MD, discusses the long-term data supporting ropeginterferon alfa-2b-njft as treatment in patients with polycythemia vera.

Pint Pharma and PharmaEssentia announced today that ANVISA (Brazilian Health Regulatory Agency) has approved BESREMi® ...

New milestone achieved in Astellas T-cell engager collaboration: In February 2025, Astellas advanced the second program to GLP toxicology studies, triggering a $5 million milestone payment to CytomX.

Like most plasma membrane proteins, type I interferon (IFN) receptor (IFNAR) traffics from the outer surface to the inner compartments of the cell. Long considered as a passive means to simply control ...

“The Alfa Junior is a lot of fun in Veloce form… just know the range means you’ll be having that fun briefly” A new Alfa Romeo? Exciting. Curb your enthusiasm. It's probably not the new ...

These include Merck’s (MRK) Keytruda, approved in 2020; Adstiladrin, approved in 2022, works by delivering a virus carrying the gene for interferon alfa-2b directly into the bladder to stimulate ...

The interferon (IFN) family of proteins plays key roles in the immune response against viruses and other pathogens. In the context of COVID-19, IFNs have been shown to be key for restraining ...

BESREMi® (ropeginterferon alfa-2b) is a long-acting, mono-pegylated proline interferon (ATC L03AB15). It is administered once every 2 weeks initially, or up to every 4 weeks after stabilization ...

Investopedia / Mira Norian Generation Alpha is the name given to those born between 2010 and 2024. Generation Alpha is the first generation born entirely in the 21st century, between 2010 and 2024.